Public Health

Trump calls politicians who refuse to say they received Covid boosters 'gutless'

Wed, 2022-01-12 10:15 — mike kraft

WASHINGTON — Former President Donald Trump on Tuesday criticized politicians who refuse to say whether they’ve received a Covid booster shot.

In an interview with far-right cable channel One America News, Trump said he received the booster and has seen politicians get asked in interviews whether they’ve also gotten a third shot.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Trump calls politicians who refuse to say they received Covid boosters 'gutless'
Log in or register to post comments

Face masks can reduce distance droplets travel by half, new study suggests

Wed, 2022-01-12 10:04 — mike kraft

Face masks can reduce distance droplets travel by half, new study suggests Wearing a face mask can reduce the distance that aerosols and droplets travel when someone is speaking or coughing – possibly by half, a new study suggests. By Jack Guy, Hannah Strange, <a href="/profiles/rhea-mogul">Rhea Mogul</a> and Adam Renton, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Face masks can reduce distance droplets travel by half, new study suggests
Log in or register to post comments

Study: Covid loses '90pc of its infectiousness within five minutes of being airborne'

Wed, 2022-01-12 09:55 — mike kraft

Covid loses '90pc of its infectiousness within five minutes of being airborne' Coronavirus loses 90 per cent of its infectiousness within five minutes of becoming airborne, a new study has suggested. YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Study: Covid loses '90pc of its infectiousness within five minutes of being airborne'
Log in or register to post comments

Pfizer study shows COVID-19 booster can be given along with pneumonia shot

Wed, 2022-01-12 09:46 — mike kraft

Pfizer study shows COVID-19 booster can be given along with pneumonia shot Pfizer Inc said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and immune responses in people aged 65 and above in a late-stage study. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Pfizer study shows COVID-19 booster can be given along with pneumonia shot
Log in or register to post comments

Study indicates Moderna COVID-19 Shot Lowers Risk Of Infection, Hospitalization Compared To Pfizer's

Wed, 2022-01-12 09:39 — mike kraft

Moderna COVID-19 Shot Lowers Risk Of Infection, Hospitalization Compared To Pfizer's, VA Real-World Data Shows A new real-world study funded by the Department of Veterans Affairs (VA) showed that compared to those who received Pfizer Inc's (NYSE: PFE) COVID-19 vaccine, Moderna Inc (NASDAQ: MRNA) vaccine recipients had a significantly lower risk of SARS-CoV-2 infection and related hospitalizations. Lower risk was observed across all age groups, comorbidity-burden categories, and race.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Study indicates Moderna COVID-19 Shot Lowers Risk Of Infection, Hospitalization Compared To Pfizer's
Log in or register to post comments

White House plans vows to provide 10 million Covid tests for schools each month

Wed, 2022-01-12 09:31 — mike kraft

The Biden administration announced Wednesday that it would provide schools with 10 million Covid-19 tests every month as it urges districts to keep classrooms open amid a widespread shortage of testing kits.

The White House said it will distribute 5 million rapid tests to schools every month. It also vowed to make the capacity for an additional 5 million PCR tests available through a Department of Health and Human Services program that collects samples and sends them to labs.

Country / Region Tags:

General Topic Tags: